Of note, initial IFITM1 and IFITM3 expression levels in influenza patients remained unchanged at the end of the follow-up period, and their dynamics were not associated with the risk of AKIN and secondary infection (Supplementary Fig. S3). Here, IFITM1 is linked to influenza.